David, Abel P.
Biswas, Sushobhan
Soltis, Macey P.
Eltawil, Yasmin
Zhou, Ruiqi
Easow, Sarah A.
Cheng, Alan G.
Heller, Stefan
Jan, Taha A. https://orcid.org/0000-0001-8971-7769
Funding for this research was provided by:
National Institute on Deafness and Other Communication Disorders (K08DC019683, T32DC015209, R01DC021110, R01DC020879, R01DC016919, R01DC015201, R21DC022058)
Article History
Received: 23 December 2024
Accepted: 23 February 2025
First Online: 13 March 2025
Declarations
:
: S.H. is a paid consultant of Pipeline Therapeutics. T.A.J is a site investigator for Akouos, Inc. for two on-going clinical trials (NCT05572073 and NCT05821959) but does not receive consulting fees or hold stock investments. T.A.J is a consultant for Merck Manuals for book chapter editing. The remaining authors declare no competing interests.